EverlyWell announced Tuesday that is has raised $2.5 million in seed funding and launched a beta test of its at-home healthcare diagnostics tests.
The Austin-based company is led by CEO Julia Cheek, who recently moved to Austin from Dallas. The startup has six employees and its headquarters is at West 6th Street and Guadalupe.
“We are pleased to launch our business in a vibrant market like Austin, which is known for its creativity and cutting-edge innovation,” Cheek said in a news release. “We want to be centered among the brightest, most entrepreneurial minds who can help us revolutionize the health testing industry. Our promise to consumers is to deliver a world-class product that simplifies the testing process and provides actionable, easy-to-read results that will help them take ownership of their own health.”
The company is creating diagnostics tests for food sensitivity, fertility, hormone health and more aimed at consumers. The kits are mailed to consumers’ homes with instructions on completing the test and mailing it back. Kit samples are collected via pinprick dried blood spot, saliva or urine. Once the lab receives the test and processes it within a few days, the results and data are transmitted to the consumer electronically in an easy to read format. All of the testing is done without a lab or doctor’s visit in the privacy of the person’s home.
To analyze its tests, EverlyWell is partnering with CLIA-certified laboratories and a national physician network to review customer results.
“Diagnostic testing is a subpar experience for the individual,” Dr. Murdoc Khaleghi, EverlyWell’s Chief Medical Officer, said in a news release. “EverlyWell has developed an innovative platform that places the consumer at the center, empowering the individual to order, understand, and improve their own biomarkers. Health information is a powerful tool in preventing long-term and chronic disease, and ultimately should be accessible and understandable to all.”